A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers

NCT02248077 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was redesigned in collaboration with CMS before it started.

Conditions

Impaired Wound Healing

Interventions

DEVICE: AutoloGel
OTHER: Usual and Customary Care (UCC)

Sponsor

Cytomedix